Literature DB >> 23416214

Induction of protective immunity against Chlamydia muridarum intravaginal infection with the chlamydial immunodominant antigen macrophage infectivity potentiator.

Chunxue Lu1, Bo Peng, Zhihong Li, Lei Lei, Zhongyu Li, Lili Chen, Qingzhi He, Guangming Zhong, Yimou Wu.   

Abstract

We previously reported that 5 Chlamydia muridarum antigens reacted with antisera from >90% mice urogenitally infected with C. muridarum and they are TC0660 (ABC transporter or ArtJ), TC0727 (outer membrane complex protein B or OmcB), TC0828 (macrophage infectivity potentiator or MIP), TC0726 (inclusion membrane protein or Inc) & TC0268 (hypothetical protein or HP). The orthologs of these antigens in Chlamydia trachomatis were also highly reactive with antisera from women urogenitally infected with C. trachomatis. In the current study, we evaluated these C. muridarum antigens for their ability to induce protection against a C. muridarum intravaginal challenge infection in mice. We found that only MIP induced the most pronounced protection against C. muridarum infection. The protection correlated well with robust C. muridarum MIP-specific antibody and Th1-dominant T cell responses. The MIP-immunized mice displayed significantly reduced live organism shedding from the lower genital tract and highly attenuated inflammatory pathologies in the upper genital tissues. These results demonstrate that MIP, an immunodominant antigen identified by both human and mouse antisera, may be considered a component of a multi-subunit chlamydial vaccine for inducing protective immunity.
Copyright © 2013 Institut Pasteur. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23416214      PMCID: PMC4218745          DOI: 10.1016/j.micinf.2013.02.001

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  41 in total

Review 1.  Immunity to murine chlamydial genital infection.

Authors:  Richard P Morrison; Harlan D Caldwell
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

2.  Mapping immunodominant antigens and H-2-linked antibody responses in mice urogenitally infected with Chlamydia muridarum.

Authors:  Hao Zeng; Shuping Hou; Siqi Gong; Xiaohua Dong; Quanming Zou; Guangming Zhong
Journal:  Microbes Infect       Date:  2012-03-03       Impact factor: 2.700

3.  Trachoma vaccine trial in India: results of two-year follow-up.

Authors:  S P Dhir; L P Agarwal; S B Gupta; R Detels; S P Wang; J T Grayston
Journal:  Indian J Med Res       Date:  1968-08       Impact factor: 2.375

4.  Priming with Chlamydia trachomatis major outer membrane protein (MOMP) DNA followed by MOMP ISCOM boosting enhances protection and is associated with increased immunoglobulin A and Th1 cellular immune responses.

Authors:  Z Dong-Ji; X Yang; C Shen; H Lu; A Murdin; R C Brunham
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

5.  Immunity to murine Chlamydia trachomatis genital tract reinfection involves B cells and CD4(+) T cells but not CD8(+) T cells.

Authors:  S G Morrison; H Su; H D Caldwell; R P Morrison
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

6.  Subclinical chlamydial infection of the female mouse genital tract generates a potent protective immune response: implications for development of live attenuated chlamydial vaccine strains.

Authors:  H Su; R Messer; W Whitmire; S Hughes; H D Caldwell
Journal:  Infect Immun       Date:  2000-01       Impact factor: 3.441

Review 7.  Cellular immunity and Chlamydia genital infection: induction, recruitment, and effector mechanisms.

Authors:  Kathleen A Kelly
Journal:  Int Rev Immunol       Date:  2003 Jan-Feb       Impact factor: 5.311

8.  A novel recombinant multisubunit vaccine against Chlamydia.

Authors:  Francis O Eko; Qing He; Teresa Brown; Lucinda McMillan; Godwin O Ifere; Godwin A Ananaba; Deborah Lyn; Werner Lubitz; Kathryn L Kellar; Carolyn M Black; Joseph U Igietseme
Journal:  J Immunol       Date:  2004-09-01       Impact factor: 5.422

9.  An inclusion membrane protein from Chlamydia trachomatis enters the MHC class I pathway and stimulates a CD8+ T cell response.

Authors:  Michael N Starnbach; Wendy P Loomis; Pam Ovendale; David Regan; Bruce Hess; Mark R Alderson; Steven P Fling
Journal:  J Immunol       Date:  2003-11-01       Impact factor: 5.422

10.  DNA immunization with pgp3 gene of Chlamydia trachomatis inhibits the spread of chlamydial infection from the lower to the upper genital tract in C3H/HeN mice.

Authors:  Manuela Donati; Vittorio Sambri; Maurizio Comanducci; Korinne Di Leo; Elisa Storni; Lorenzo Giacani; Giulio Ratti; Roberto Cevenini
Journal:  Vaccine       Date:  2003-03-07       Impact factor: 3.641

View more
  18 in total

1.  The Cryptic Plasmid Improves Chlamydia Fitness in Different Regions of the Gastrointestinal Tract.

Authors:  Jingyue Ma; Conghui He; Zhi Huo; Ying Xu; Bernard Arulanandam; Quanzhong Liu; Guangming Zhong
Journal:  Infect Immun       Date:  2020-02-20       Impact factor: 3.441

2.  Intravenous Inoculation with Chlamydia muridarum Leads to a Long-Lasting Infection Restricted to the Gastrointestinal Tract.

Authors:  Jin Dai; Tianyuan Zhang; Luying Wang; Lili Shao; Cuiming Zhu; Yuyang Zhang; Courtney Failor; Robert Schenken; Joel Baseman; Cheng He; Guangming Zhong
Journal:  Infect Immun       Date:  2016-07-21       Impact factor: 3.441

3.  Nonpathogenic Colonization with Chlamydia in the Gastrointestinal Tract as Oral Vaccination for Inducing Transmucosal Protection.

Authors:  Luying Wang; Cuiming Zhu; Tianyuan Zhang; Qi Tian; Nu Zhang; Sandra Morrison; Richard Morrison; Min Xue; Guangming Zhong
Journal:  Infect Immun       Date:  2018-01-22       Impact factor: 3.441

Review 4.  Genital Chlamydia trachomatis: understanding the roles of innate and adaptive immunity in vaccine research.

Authors:  Sam Vasilevsky; Gilbert Greub; Denise Nardelli-Haefliger; David Baud
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

5.  The Plasmid-Encoded pGP3 Promotes Chlamydia Evasion of Acidic Barriers in Both Stomach and Vagina.

Authors:  Tianyuan Zhang; Zhi Huo; Jingyue Ma; Cheng He; Guangming Zhong
Journal:  Infect Immun       Date:  2019-04-23       Impact factor: 3.441

6.  The Genital Tract Virulence Factor pGP3 Is Essential for Chlamydia muridarum Colonization in the Gastrointestinal Tract.

Authors:  Lili Shao; Tianyuan Zhang; Jose Melero; Yumeng Huang; Yuanjun Liu; Quanzhong Liu; Cheng He; David E Nelson; Guangming Zhong
Journal:  Infect Immun       Date:  2017-12-19       Impact factor: 3.441

7.  Distinct Roles of Chromosome- versus Plasmid-Encoded Genital Tract Virulence Factors in Promoting Chlamydia muridarum Colonization in the Gastrointestinal Tract.

Authors:  John J Koprivsek; Tianyuan Zhang; Qi Tian; Ying He; Hong Xu; Zhenming Xu; Guangming Zhong
Journal:  Infect Immun       Date:  2019-07-23       Impact factor: 3.441

8.  Recombinant protein truncation strategy for inducing bactericidal antibodies to the macrophage infectivity potentiator protein of Neisseria meningitidis and circumventing potential cross-reactivity with human FK506-binding proteins.

Authors:  Magdalena K Bielecka; Nathalie Devos; Mélanie Gilbert; Miao-Chiu Hung; Vincent Weynants; John E Heckels; Myron Christodoulides
Journal:  Infect Immun       Date:  2014-12-01       Impact factor: 3.441

9.  Chlamydia muridarum with Mutations in Chromosomal Genes tc0237 and/or tc0668 Is Deficient in Colonizing the Mouse Gastrointestinal Tract.

Authors:  Lili Shao; Tianyuan Zhang; Quanzhong Liu; Jie Wang; Guangming Zhong
Journal:  Infect Immun       Date:  2017-07-19       Impact factor: 3.441

10.  Signaling via tumor necrosis factor receptor 1 but not Toll-like receptor 2 contributes significantly to hydrosalpinx development following Chlamydia muridarum infection.

Authors:  Xiaohua Dong; Yuanjun Liu; Xiaotong Chang; Lei Lei; Guangming Zhong
Journal:  Infect Immun       Date:  2014-02-18       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.